US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6710174B2
(en)
*
|
2001-09-13 |
2004-03-23 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of vascular endothelial growth factor receptor-1 expression
|
GB9410534D0
(en)
*
|
1994-05-26 |
1994-07-13 |
Lynxvale Ltd |
Improvements in or relating to growth factor inhibitors
|
GB9410533D0
(en)
*
|
1994-05-26 |
1994-07-13 |
Lynxvale Ltd |
In situ hybridisation and immuno-Chemical localisation of a growth factor
|
JPH09154588A
(ja)
|
1995-10-07 |
1997-06-17 |
Toagosei Co Ltd |
Vegf結合性ポリペプチド
|
US7034009B2
(en)
|
1995-10-26 |
2006-04-25 |
Sirna Therapeutics, Inc. |
Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
|
US6346398B1
(en)
|
1995-10-26 |
2002-02-12 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
|
GB9601640D0
(en)
*
|
1996-01-26 |
1996-03-27 |
Cancer Res Campaign Tech |
Ligand directed enzyme prodrug therapy
|
US6100071A
(en)
|
1996-05-07 |
2000-08-08 |
Genentech, Inc. |
Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
|
DE69733204T3
(de)
|
1996-07-15 |
2012-03-08 |
Chugai Seiyaku K.K. |
Neuartige vegf-ähnliche faktoren
|
JP2001501471A
(ja)
*
|
1996-09-24 |
2001-02-06 |
メルク エンド カンパニー インコーポレーテッド |
血管新生の阻害のための遺伝子治療
|
US6750044B1
(en)
*
|
1996-10-17 |
2004-06-15 |
Genentech, Inc. |
Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
|
JP3837748B2
(ja)
|
1997-01-17 |
2006-10-25 |
東亞合成株式会社 |
Vegf結合性ポリペプチド
|
EP1086705A4
(de)
*
|
1998-05-20 |
2002-02-06 |
Kyowa Hakko Kogyo Kk |
Inhibitoren der aktivität des vaskularen endothelialen wachstumsfaktors
|
US6200954B1
(en)
*
|
1998-09-04 |
2001-03-13 |
National University Of Singapore |
Small peptides having potent anti-angiogenic activity
|
US7317003B2
(en)
*
|
1998-09-04 |
2008-01-08 |
National University Of Singapore |
Small peptides having anti-angiogenic and endothelial cell inhibition activity
|
US6696063B1
(en)
*
|
1998-12-30 |
2004-02-24 |
Applied Research Systems Ars Holding N.V. |
Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy
|
CA2359461A1
(en)
*
|
1999-01-15 |
2000-07-20 |
Medstar Research Institute |
Inhibiting development of microvessels within vascular walls
|
US7303746B2
(en)
*
|
1999-06-08 |
2007-12-04 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating eye disorders with modified chimeric polypeptides
|
US6833349B2
(en)
*
|
1999-06-08 |
2004-12-21 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating inflammatory skin diseases
|
US7070959B1
(en)
|
1999-06-08 |
2006-07-04 |
Regeneron Pharmaceuticals, Inc. |
Modified chimeric polypeptides with improved pharmacokinetic properties
|
GB9928950D0
(en)
*
|
1999-12-07 |
2000-02-02 |
Metris Therapeutics Limited |
Binding protein
|
US20030036524A1
(en)
*
|
2000-03-08 |
2003-02-20 |
Jens Licthenberg |
Method of sensitising endothelial cells to prodrugs
|
EP1581615B1
(de)
|
2000-09-05 |
2010-04-28 |
Biosight Ltd |
Peptid-konjugierte antikrebs-prodrugs
|
US6734017B2
(en)
|
2001-09-28 |
2004-05-11 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of vascular endothelial growth factor receptor-2 expression
|
AU2003215163A1
(en)
*
|
2002-02-12 |
2003-09-04 |
Vanderbilt University |
Inhibition of vegf receptor signaling reverses tumor resistance to radiotherapy
|
US20040101478A1
(en)
*
|
2002-03-29 |
2004-05-27 |
Thomas Kenneth A |
In vivo methods of determining activity of receptor-type kinase inhibitors
|
CU23178A1
(es)
*
|
2002-04-15 |
2006-09-22 |
Ct Ingenieria Genetica Biotech |
INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA
|
CN103073620B
(zh)
*
|
2002-09-12 |
2014-12-10 |
肿瘤疗法科学股份有限公司 |
Kdr肽和包括该肽的疫苗
|
US7432341B2
(en)
*
|
2002-10-24 |
2008-10-07 |
Valo Hsj, Limited Partnership |
Cytokine receptor modulators and method of modulating cytokine receptor activity
|
US20040266688A1
(en)
*
|
2003-05-14 |
2004-12-30 |
Nayak Nihar R |
Methods for modulating endometrium
|
AU2004265226A1
(en)
*
|
2003-05-16 |
2005-02-24 |
Receptor Biologix, Inc. |
Intron fusion proteins, and methods of identifying and using same
|
US7186699B2
(en)
*
|
2003-06-03 |
2007-03-06 |
Cell Genesys, Inc. |
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
|
WO2005069906A2
(en)
*
|
2004-01-16 |
2005-08-04 |
Yale University |
Methods and compositions relating to vascular endothelial growth factor and th2 mediated inflammatory diseases
|
US8618054B2
(en)
*
|
2004-05-05 |
2013-12-31 |
Valorisation-Rechereche Société en Commandite |
Interleukin-1 receptor antagonists, compositions, and methods of treatment
|
WO2005113596A2
(en)
*
|
2004-05-14 |
2005-12-01 |
Receptor Biologix, Inc. |
Cell surface receptor isoforms and methods of identifying and using the same
|
JP4680997B2
(ja)
*
|
2004-06-08 |
2011-05-11 |
ツェンドゥー カンホン バイオテクノロジーズ カンパニー リミテッド |
血管新生を阻害するキメラタンパク質およびその利用
|
US20080171033A1
(en)
*
|
2004-08-26 |
2008-07-17 |
Chiwen Chang |
Compositions and methods for treating diseases associated with angiogenesis and inflammation
|
EP1804835B9
(de)
|
2004-09-13 |
2010-09-29 |
Genzyme Corporation |
Multimere konstrukte
|
US8841259B2
(en)
*
|
2005-02-24 |
2014-09-23 |
Joslin Diabetes Center |
Compositions and methods for treating vascular permeability
|
EP2289533B1
(de)
|
2005-02-28 |
2013-09-18 |
Oncotherapy Science, Inc. |
Aus vaskulärem Endothelwachstumsfaktor-Rezeptor 1 gewonnene Epitoppeptide und Impfstoffe mit diesen Peptiden
|
US20060234347A1
(en)
*
|
2005-04-13 |
2006-10-19 |
Harding Thomas C |
Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
|
US20090170769A1
(en)
*
|
2005-05-13 |
2009-07-02 |
Pei Jin |
Cell surface receptor isoforms and methods of identifying and using the same
|
WO2007009071A2
(en)
*
|
2005-07-13 |
2007-01-18 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating an inflammatory response
|
US9198981B2
(en)
*
|
2006-02-01 |
2015-12-01 |
The University Of Kentucky |
Modulation of angiogenesis
|
US20100119512A1
(en)
*
|
2007-01-25 |
2010-05-13 |
Joslin Diabetes Center |
Methods of diagnosing, treating, and preventing increased vascular permeability
|
TWI436775B
(zh)
|
2007-08-24 |
2014-05-11 |
Oncotherapy Science Inc |
以抗原胜肽合併化療藥劑治療胰臟癌
|
RU2010133157A
(ru)
|
2008-01-07 |
2012-02-20 |
Орто-Клиникал Дайэгностикс, Инк. (Us) |
Определение комплекса sflt-1:ангиогенный фактор
|
WO2009149205A2
(en)
*
|
2008-06-03 |
2009-12-10 |
Neurotech Usa, Inc. |
Cell lines that secrete soluble vegf receptors and uses thereof
|
WO2010091234A2
(en)
|
2009-02-06 |
2010-08-12 |
The General Hospital Corporation |
Methods of treating vascular lesions
|
WO2010108503A1
(en)
|
2009-03-24 |
2010-09-30 |
Life & Brain Gmbh |
Promotion of neuronal integration in neural stem cell grafts
|
TW201109029A
(en)
|
2009-06-11 |
2011-03-16 |
Oncotherapy Science Inc |
Vaccine therapy for choroidal neovascularization
|
ES2354922B1
(es)
|
2009-09-02 |
2012-02-07 |
Fundacion Institut De Recerca De L'hospital Universitari Vall D'hebron |
Marcadores para la selección de terapias personalizadas para el tratamiento del c�?ncer.
|
WO2011028642A1
(en)
|
2009-09-04 |
2011-03-10 |
University Of Louisville Research Foundation, Inc. |
Genetic determinants of prostate cancer risk
|
SI2601214T1
(en)
|
2010-08-06 |
2018-03-30 |
Genzyme Corporation |
VEGF antagonist compositions and their use
|
JO3283B1
(ar)
|
2011-04-26 |
2018-09-16 |
Sanofi Sa |
تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
|
TWI702955B
(zh)
|
2012-05-15 |
2020-09-01 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
AU2014205369B2
(en)
|
2013-01-11 |
2018-08-09 |
Massachusetts Eye And Ear Infirmary |
CYP450 lipid metabolites reduce inflammation and angiogenesis
|
EP2994758B1
(de)
|
2013-05-08 |
2017-12-20 |
Opthea Limited |
Biomarker für altersbedingte makuladegeneration (amd)
|
US9914769B2
(en)
|
2014-07-15 |
2018-03-13 |
Kymab Limited |
Precision medicine for cholesterol treatment
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
AU2015231439B2
(en)
|
2014-03-17 |
2019-11-14 |
Adverum Biotechnologies, Inc. |
Compositions and methods for enhanced gene expression in cone cells
|
KR101819135B1
(ko)
|
2014-03-18 |
2018-01-18 |
한국과학기술원 |
당화 vegf 디코이 수용체 융합 단백질
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
EP3170005B1
(de)
|
2014-07-18 |
2019-04-10 |
Sanofi |
Verfahren zur vorhersage des ausgangs einer behandlung mit aflibercept bei einem patienten mit verdacht auf ein krebsleiden
|
KR20170137730A
(ko)
|
2015-03-02 |
2017-12-13 |
애드베룸 바이오테크놀로지스, 인코포레이티드 |
망막 추상체에 폴리뉴클레오타이드의 유리체 내 전달을 위한 조성물 및 방법
|
GB2545763A
(en)
|
2015-12-23 |
2017-06-28 |
Adverum Biotechnologies Inc |
Mutant viral capsid libraries and related systems and methods
|
CN108712911A
(zh)
|
2015-12-30 |
2018-10-26 |
科达制药股份有限公司 |
抗体及其缀合物
|
AU2017257169B2
(en)
|
2016-04-29 |
2021-07-08 |
Adverum Biotechnologies, Inc. |
Evasion of neutralizing antibodies by a recombinant adeno-associated virus
|
WO2017218981A2
(en)
|
2016-06-16 |
2017-12-21 |
Adverum Biotechnologies, Inc. |
Compositions and methods for reducing ocular neovascularization
|
CA3040179A1
(en)
|
2016-10-19 |
2018-04-26 |
Adverum Biotechnologies, Inc. |
Modified aav capsids and uses thereof
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
WO2018170473A1
(en)
|
2017-03-17 |
2018-09-20 |
Adverum Biotechnologies, Inc. |
Compositions and methods for enhanced gene expression
|
WO2019147944A1
(en)
|
2018-01-26 |
2019-08-01 |
The Regents Of The University Of California |
Methods and compositions for treatment of angiogenic disordres using anti-vegf agents
|
JP7384815B2
(ja)
*
|
2018-03-22 |
2023-11-21 |
ザ チルドレンズ メディカル センター コーポレーション |
肺の修復に関する方法および組成物
|
TW202106699A
(zh)
|
2019-04-26 |
2021-02-16 |
美商愛德維仁生物科技公司 |
用於玻璃體內遞送之變異體aav蛋白殼
|
JP2022553640A
(ja)
|
2019-10-10 |
2022-12-26 |
コディアック サイエンシーズ インコーポレイテッド |
眼障害を処置する方法
|
CN114867487A
(zh)
|
2019-11-25 |
2022-08-05 |
加利福尼亚大学董事会 |
用于眼内新生血管的长效vegf抑制剂
|
JP2024519888A
(ja)
|
2021-05-28 |
2024-05-21 |
上海瑞宏迪医薬有限公司 |
カプシド変異を有する組換えアデノ随伴ウイルス及びその応用
|
CA3233983A1
(en)
*
|
2021-11-02 |
2023-05-11 |
Ole-Jan Iversen (Deceased) |
Tri-, tetra and pentapeptides, compositions thereof and their use in the therapy of psoriasis
|